Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Title

Type your Poster Title, then hit apply

Showing 1,267 results.

Thumbnail for GLP-1 Receptor Agonist Exposure and Survival Outcomes in Newly Diagnosed Multiple Myeloma Treated With Daratumumab-Based Quadruplet Therapy: A Target Trial Emulation

MM - 626

GLP-1 Receptor Agonist Exposure and Survival Outcomes in Newly Diagnosed Multiple Myeloma Treated With Daratumumab-Based Quadruplet Therapy: A Target Trial Emulation

Colton Jones

Poster Presenter: Colton Jones

Thumbnail for GLP-1 Receptor Agonists and Major Clinical Outcomes in Adults With Classic Myeloproliferative Neoplasms and Type 2 Diabetes and/or Obesity: A Global Propensity Score-Matched Analysis

MPN - 1144

GLP-1 Receptor Agonists and Major Clinical Outcomes in Adults With Classic Myeloproliferative Neoplasms and Type 2 Diabetes and/or Obesity: A Global Propensity Score-Matched Analysis

Muluken Megiso

Poster Presenter: Muluken Megiso

Previous 1...55 56 57 58 59 60 61...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for GLP-1 Receptor Agonists and Organ Function Outcomes in Amyloid Light-Chain Amyloidosis: A Real-World Analysis From the TriNetX Global Collaborative Network

MM - 1350

GLP-1 Receptor Agonists and Organ Function Outcomes in Amyloid Light-Chain Amyloidosis: A Real-World Analysis From the TriNetX Global Collaborative Network

Dhriti Sood

Poster Presenter: Dhriti Sood

Thumbnail for GLP-1 Receptor Agonists and SGLT2 Inhibitors in Multiple Myeloma and Plasma Cell Disorders: Protective, Harmful, or Both? A Scoping Review

MM - 852

GLP-1 Receptor Agonists and SGLT2 Inhibitors in Multiple Myeloma and Plasma Cell Disorders: Protective, Harmful, or Both? A Scoping Review

Yagnapriya Chirrareddy

Poster Presenter: Yagnapriya Chirrareddy

Thumbnail for GLP-1 Receptor Agonists and Venous Thromboembolism Risk in Multiple Myeloma

MM - 1086

GLP-1 Receptor Agonists and Venous Thromboembolism Risk in Multiple Myeloma

Priyanshi Maurya

Poster Presenter: Priyanshi Maurya

Thumbnail for GLP-1 RECEPTOR AGONISTS ARE ASSOCIATED WITH SIGNIFICANTLY REDUCED ALL-CAUSE MORTALITY, HOSPITALIZATION, AND SEPSIS IN PATIENTS WITH MULTIPLE MYELOMA AND TYPE 2 DIABETES: A PROPENSITY-MATCHED ANALYSIS OF THE TRINETX GLOBAL COLLABORATIVE NETWORK.

MM - 837

GLP-1 RECEPTOR AGONISTS ARE ASSOCIATED WITH SIGNIFICANTLY REDUCED ALL-CAUSE MORTALITY, HOSPITALIZATION, AND SEPSIS IN PATIENTS WITH MULTIPLE MYELOMA AND TYPE 2 DIABETES: A PROPENSITY-MATCHED ANALYSIS OF THE TRINETX GLOBAL COLLABORATIVE NETWORK.

Mevlut Ozmen

Poster Presenter: Mevlut Ozmen

$Thumbnail for Golcadomide, a Potential First-in-Class, Oral Celmod ± Rituximab in the Phase 1/2 CC-99282-NHL-001 Study: Long-Term Follow-Up Results of Patients With Relapsed/Refractory Follicular Lymphoma$

IBCL - 141

Golcadomide, a Potential First-in-Class, Oral Celmod ± Rituximab in the Phase 1/2 CC-99282-NHL-001 Study: Long-Term Follow-Up Results of Patients With Relapsed/Refractory Follicular Lymphoma

Javier Munoz

Poster Presenter: Javier Munoz

Thumbnail for Golcadomide-A Potential First-in-Class Oral CELMoD Combined With Pola-R-CHP in Frontline Aggressive B-Cell Lymphoma: Safety and 12-Month Efficacy

ABCL - 142

Golcadomide-A Potential First-in-Class Oral CELMoD Combined With Pola-R-CHP in Frontline Aggressive B-Cell Lymphoma: Safety and 12-Month Efficacy

Muhamad Alhaj Moustafa

Poster Presenter: Muhamad Alhaj Moustafa

$Thumbnail for GPRC5D-Targeted Therapies in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Single-Arm Meta-Analysis$

MM - 704

GPRC5D-Targeted Therapies in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Single-Arm Meta-Analysis

Basil Joy

Poster Presenter: Basil Joy

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors